Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
life sciences
merck
national
national blog main
national top stories
new york blog main
3
×
new york top stories
purdue pharma
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
clinical trials
detroit blog main
detroit top stories
diagnostics
hepatitis b
ifm therapeutics
indiana blog main
indiana top stories
microbiome
moderna
novartis
pfizer
What
bio
3
×
drug
3
×
roundup
pricing
acquisitions
advanced
advantages
arrival
award
bar
biggest
brings
build
buy
cancer
ceo
company’s
daniel
data
death
debut
decades
dems
dyne’s
expect
gamble
gilead
given
immunotherapy
longer
lung
market
medco’s
medical
microbiome
mover
moves
new
openly
o’day
Language
unset
3
×
Current search:
bio
×
unset
×
" new york blog main "
×
drug
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone